Company: SHPH
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022162
Chunk: 11

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part II, Item 1A
Chunk 11
---
 duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.

    SHUTTLE
    PHARMACEUTICALS HOLDINGS, INC.

    November
    13, 2025
    By:
    /s/
    Christopher Cooper

    Christopher
    Cooper

    Interim
    Chief Executive Officer

    (Principal
    Executive Officer)

    November
    13, 2025
    By:
    /s/
    Timothy J. Lorber

    Timothy
    J. Lorber
    Chief
    Financial Officer

    (Principal
    Financial and Accounting Officer)

36